Terms: = Pancreatic cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12
184 results:
1. Influence of aberrant right hepatic artery on survival after pancreatic resection for ductal adenocarcinoma of the pancreatic head.
Petrova E; Mazzella E; Eichler K; Gruber-Rouh T; Schulze F; Bechstein WO; Schnitzbauer AA
Langenbecks Arch Surg; 2024 Apr; 409(1):111. PubMed ID: 38587539
[TBL] [Abstract] [Full Text] [Related]
2. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases.
Karim S; Seidensticker R; Seidensticker M; Ricke J; Schinner R; Treitl K; Rübenthaler J; Ingenerf M; Schmid-Tannwald C
Radiol Oncol; 2024 Mar; 58(1):33-42. PubMed ID: 38378033
[TBL] [Abstract] [Full Text] [Related]
3. Long-term use of anti-cholesterol drugs and cancer risks in a Japanese population.
Okita Y; Sobue T; Zha L; Kitamura T; Iwasaki M; Inoue M; Yamaji T; Tsugane S; Sawada N
Sci Rep; 2024 Feb; 14(1):2896. PubMed ID: 38316869
[TBL] [Abstract] [Full Text] [Related]
4. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.
Overbeek KA; Poulsen JL; Lanzillotta M; Vinge-Holmquist O; Macinga P; Demirci AF; Sindhunata DP; Backhus J; Algül H; Buijs J; Levy P; Kiriukova M; Goni E; Hollenbach M; Miksch RC; Kunovsky L; Vujasinovic M; Nikolic S; Dickerson L; Hirth M; Neurath MF; Zumblick M; Vila J; Jalal M; Beyer G; Frost F; Carrara S; Kala Z; Jabandziev P; Sisman G; Akyuz F; Capurso G; Falconi M; Arlt A; Vleggaar FP; Barresi L; Greenhalf B; Czakó L; Hegyi P; Hopper A; Nayar MK; Gress TM; Vitali F; Schneider A; Halloran CM; Trna J; Okhlobystin AV; Dagna L; Cahen DL; Bordin D; Rebours V; Mayerle J; Kahraman A; Rasch S; Culver E; Kleger A; Martínez-Moneo E; Røkke O; Hucl T; Olesen SS; Bruno MJ; Della-Torre E; Beuers U; Löhr JM; Rosendahl J;
Clin Gastroenterol Hepatol; 2024 May; 22(5):994-1004.e10. PubMed ID: 38184096
[TBL] [Abstract] [Full Text] [Related]
5. Air quality and cancer risk in the All of Us Research Program.
Craver A; Luo J; Kibriya MG; Randorf N; Bahl K; Connellan E; Powell J; Zakin P; Jones RR; Argos M; Ho J; Kim K; Daviglus ML; Greenland P; Ahsan H; Aschebrook-Kilfoy B
Cancer Causes Control; 2024 May; 35(5):749-760. PubMed ID: 38145439
[TBL] [Abstract] [Full Text] [Related]
6. Ultrasonographic Features of Nonneoplastic Protrusions in pancreatic Cysts by Contrast-Enhanced Endoscopic Ultrasound.
Hisa T; Kudo A; Shimizu T; Nishiyama S; Yamada T; Osera S; Fukushima H; Tomori A
Pancreas; 2023 Jul; 52(6):e328-e334. PubMed ID: 38015069
[TBL] [Abstract] [Full Text] [Related]
7. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data.
Jia K; Kundrot S; Palchuk MB; Warnick J; Haapala K; Kaplan ID; Rinard M; Appelbaum L
EBioMedicine; 2023 Dec; 98():104888. PubMed ID: 38007948
[TBL] [Abstract] [Full Text] [Related]
8. A systematic review meta-analysis and meta-regression on the implications of an aberrant right hepatic artery in patients undergoing pancreaticoduodenectomy for the treatment of malignant disease.
Chorti A; Bontinis V; Bontinis A; Alifieris CE; Chatziantoniou G; Karlafti E; Michalopoulos A; Paramythiotis D
Minerva Surg; 2024 Feb; 79(1):82-91. PubMed ID: 37955856
[TBL] [Abstract] [Full Text] [Related]
9. Variations of the hepatic artery and bile duct in patients with pancreaticobiliary maljunction: Impact on postoperative outcomes.
Takada S; Uchida H; Hinoki A; Shirota C; Sumida W; Tainaka T; Makita S; Takimoto A; Nakagawa Y; Maeda T
J Hepatobiliary Pancreat Sci; 2023 Nov; 30(11):1241-1248. PubMed ID: 37876298
[TBL] [Abstract] [Full Text] [Related]
10. CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.
Samain R; Maiques O; Monger J; Lam H; Candido J; George S; Ferrari N; KohIhammer L; Lunetto S; Varela A; Orgaz JL; Vilardell F; Olsina JJ; Matias-Guiu X; Sarker D; Biddle A; Balkwill FR; Eyles J; Wilkinson RW; Kocher HM; Calvo F; Wells CM; Sanz-Moreno V
Sci Adv; 2023 Oct; 9(42):eadi0244. PubMed ID: 37851808
[TBL] [Abstract] [Full Text] [Related]
11. Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer.
Englisch C; Moik F; Thaler J; Koder S; Mackman N; Preusser M; Pabinger I; Ay C
Haematologica; 2024 Apr; 109(4):1128-1136. PubMed ID: 37822244
[TBL] [Abstract] [Full Text] [Related]
12. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
[TBL] [Abstract] [Full Text] [Related]
13. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
Wainberg ZA; Melisi D; Macarulla T; Pazo Cid R; Chandana SR; De La Fouchardière C; Dean A; Kiss I; Lee WJ; Goetze TO; Van Cutsem E; Paulson AS; Bekaii-Saab T; Pant S; Hubner RA; Xiao Z; Chen H; Benzaghou F; O'Reilly EM
Lancet; 2023 Oct; 402(10409):1272-1281. PubMed ID: 37708904
[TBL] [Abstract] [Full Text] [Related]
14. Impact of body composition for patients with hepatocellular carcinoma who received atezolizumab plus bevacizumab therapy.
Uojima H; Chuma M; Hidaka H; Tsuda T; Kobayashi S; Hattori N; Ogushi K; Arase Y; Take A; Sakaguchi Y; Tomoko A; Nishigori S; Wanatanbe T; Numata K; Morimoto M; Kagawa T; Kako M; Kusano C
Eur J Gastroenterol Hepatol; 2023 Aug; 35(8):865-873. PubMed ID: 37395239
[TBL] [Abstract] [Full Text] [Related]
15. Mortality Benefit of a Blood-Based Biomarker Panel for Lung cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort.
Irajizad E; Fahrmann JF; Marsh T; Vykoukal J; Dennison JB; Long JP; Do KA; Feng Z; Hanash S; Ostrin EJ
J Clin Oncol; 2023 Sep; 41(27):4360-4368. PubMed ID: 37379494
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive analysis reveals the involvement of hsa_circ_0037858/miR-5000-
Nianyong Y; Li G
Aging (Albany NY); 2023 Jun; 15(12):5399-5411. PubMed ID: 37379126
[TBL] [Abstract] [Full Text] [Related]
17. Association between the Environmental Quality Index and Textbook Outcomes Among Medicare Beneficiaries Undergoing Surgery for Early-Stage pancreatic Adenocarcinoma.
Shaikh CF; Woldesenbet S; Munir MM; Moazzam Z; Endo Y; Alaimo L; Azap L; Yang J; Katayama E; Lima HA; Dawood Z; Pawlik TM
J Gastrointest Surg; 2023 Sep; 27(9):1883-1892. PubMed ID: 37340109
[TBL] [Abstract] [Full Text] [Related]
18. Solasodine suppresses the metastasis of gastric cancer through claudin-2 via the AMPK/STAT3/NF-κB pathway.
Su K; Yao X; Guo C; Qian C; Wang Y; Ma X; Wang X; Yang Y
Chem Biol Interact; 2023 Jul; 379():110520. PubMed ID: 37121296
[TBL] [Abstract] [Full Text] [Related]
19. Significance of anatomical resection and resection margin status in patients with HBV-related hepatocellular carcinoma and microvascular invasion: a multicenter propensity score-matched study.
Zhang XP; Xu S; Lin ZY; Gao QL; Wang K; Chen ZL; Yan ML; Zhang F; Tang YF; Zhao ZM; Li CG; Lau WY; Cheng SQ; Hu MG; Liu R
Int J Surg; 2023 Apr; 109(4):679-688. PubMed ID: 36917129
[TBL] [Abstract] [Full Text] [Related]
20. Deubiquitinating enzyme Josephin-2 stabilizes PHGDH to promote a cancer stem cell phenotype in hepatocellular carcinoma.
Wang Y; Li ZX; Wang JG; Li LH; Shen WL; Dang XW
Genes Genomics; 2023 Feb; 45(2):215-224. PubMed ID: 36583817
[TBL] [Abstract] [Full Text] [Related]
[Next]
